In the United States, trials of the SARS-CoV-2 coronavirus vaccine, developed by AstraZeneca and the University of Oxford, were temporarily stopped due to a possible adverse reaction in one of the patients. Reported by Reuters.
Testing for the efficacy and safety of the drug has been suspended in order to analyze data on side effects. At the same time, vaccine trials have resumed in the UK and Brazil.
In July, it was reported that the Russian “R-Pharm”, in agreement with AstraZeneca, will produce the Oxford vaccine against coronavirus in Russia.
A month ago, Russia announced the registration of the world's first vaccine against coronavirus. The production of Sputnik V was launched on 15 August. A number of government officials have already been vaccinated. In addition, President Vladimir Putin announced the appearance of the second vaccine variant from the Vector Center in September.
